Investments in Joint Ventures and Related Party Transactions - Summary of Carrying Amounts of Assets and Fair Value of Liabilities Included in Condensed Consolidated Balance Sheet and Maximum Loss Exposure in VIE (Detail) $ in Thousands, BRL in Millions	Sep. 30, 2015 BRL	Sep. 30, 2015 USD ($)	Dec. 31, 2014 USD ($)
Variable Interest Entity [Line Items]
Accounts receivable, net		$ 4,270	$ 4,598
Investments in Unconsolidated Joint Venture		36,185	$ 40,934
Solazyme Bunge JV
Variable Interest Entity [Line Items]
Accounts receivable, net		12
Unbilled Revenues		0
Investments in Unconsolidated Joint Venture		36,185
Loan Guarantee		0
Maximum Exposure to Loss		45,239
Solazyme Bunge JV | Bank guarantees
Variable Interest Entity [Line Items]
Maximum Exposure to Loss	BRL 35.4	8,600
Solazyme Bunge JV | Non cancelable purchase commitments
Variable Interest Entity [Line Items]
Maximum Exposure to Loss	BRL 1.7	$ 400